Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aclaris Therapts (NQ: ACRS )

18.44 USD UNCHANGED
Streaming Delayed Price Updated: 6:07 AM EST, Jan 28, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Aclaris Therapts

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Frazier Healthcare Partners Adds Highly Experienced Investor to Life Sciences Team
Frazier Healthcare Partners announced the planned addition of Albert Cha, M.D., Ph.D. as Managing Partner on the Life Sciences team. He has over 20 years of experience investing in public and private... 
From Business Wire News Releases
Gaining Ground After A Tough Couple Of Weeks
After a tumultuous start to the year, things have finally started to turn around in my day trading accounts. While it’s a low bar, ... 
Tags Warrior Trading BBIG Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers VYNE Therapeutics (NASDAQ:VYNE) shares moved upwards by 37.5% to $2.58 during Monday's regular session. ... 
Tags Market News KMPH Intraday Update
From Benzinga
Investors Snag ACRS Even Cheaper Than Its Secondary Stock Offering
Looking back to 2 days ago, Aclaris Therapeutics Inc (ACRS) priced a 5,483,714 share secondary stock offering at $17.50 per share. Buyers in that offering made a considerable investment into the... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags PACB LMAT BIVI
From Benzinga
10 Biggest Price Target Changes For Wednesday
UBS boosted Netflix Inc (NASDAQ: NFLX) price target from $540 to $650. Netflix shares rose 13.6% to $570.03 in pre-market ... 
Tags NFLX GBT Benzinga
From Benzinga
Aclaris Announces Pricing of Public Offering of Common Stock
From GlobeNewswire News Releases
Aclaris Therapeutics Soars After Promising Study Against Rheumatoid Arthritis
During the trading day yesterday, Aclaris Therapeutics’ stock shot upwards with a rise of more than 200%. 
Tags Healthcare Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BNR BLRX MCRB
From Benzinga
77 Biggest Movers From Yesterday
Gainers Gritstone Oncology, Inc. (NASDAQ: GRTS) shares jumped 248.5% to close at $22.27 on Tuesday after the company announced ... 
Tags BB STIM IDRA
From Benzinga
Best Penny Stocks To Buy Right Now? 5 For Your January Watch List
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Aclaris Announces Proposed Public Offering of Common Stock
From GlobeNewswire News Releases
Mid-Afternoon Market Update: Nasdaq Surges 1.5%; Aclaris Therapeutics Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded up 0.42% to 30,944.82 while the NASDAQ rose 1.50% to 13,193.24. The S&P also rose, ... 
Tags Eurozone Commodities Earnings
From Benzinga
Why Aclaris Therapeutics Stock Skyrocketed More Than 200% Today
Investors are excited about the biotech's clinical trial results. 
Tags ACRS Market News
From Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Aclaris Therapeutics (NASDAQ:ACRS) shares rose 194.21% to $17.3 during Tuesday's regular session. Trading ... 
Tags YTEN Market News PRPH
From Benzinga
Mid-Day Market Update: Crude Oil Rises Over 1%; ProPhase Labs Shares Plummet
Midway through trading Tuesday, the Dow traded up 0.36% to 30,924.60 while the NASDAQ rose 0.84% to 13,108.03. The S&P also rose, ... 
Tags TELL Global Penny Stocks
From Benzinga
50 Stocks Moving In Tuesday's Mid-Day Session
Gainers Aclaris Therapeutics, Inc. (NASDAQ: ACRS) shares climbed 164.3% to $15.54 after the company reported positive preliminary ... 
Tags EH LAC IZEA
From Benzinga
ACRS Stock Alert: Why Aclaris Therapeutics Is Up Over 200% Today
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Aclaris Therapeutics (ACRS) stock is soaring higher on Tuesday after... 
Tags Today's Market Market News ACRS
From InvestorPlace
Why Aclaris, Tenax, Gritstone, Merus, Minerva And Celyad Are Rallying Today
A slew of biopharma stocks are making big moves Tuesday on the back of clinical trial readouts as well announcements regarding M&A ... 
Tags Health Care News ACRS
From Benzinga
Mid-Morning Market Update: Markets Open Higher; Goldman Sachs Earnings Top Views
Following the market opening Tuesday, the Dow traded up 0.32% to 30,914.29 while the NASDAQ rose 0.90% to 13,114.92. The S&P also ... 
Tags Earnings Commodities Eurozone
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Tenax Therapeutics (NASDAQ:TENX) shares moved upwards by 75.28% to $3.12 during Tuesday's pre-market ... 
Tags TENX BHVN Movers
From Benzinga
Aclaris Therapeutics Announces Positive Preliminary Topline Data from 12-Week Phase 2a Trial of Oral ATI-450 for Moderate to Severe Rheumatoid Arthritis
From GlobeNewswire News Releases
The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags EW SPRO VCEL
From Benzinga
Stocks That Hit 52-Week Highs On Monday
This morning 301 companies reached new 52-week highs. Significant Points: The largest company by market cap to break ... 
Tags Semiconductors FLEX NOVA
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Bellicum Pharmaceuticals (NASDAQ:BLCM) shares rose 9.91% to $4.1 during Wednesday's after-market session. Trading volume ... 
Tags ALT Market News VIR
From Benzinga
The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SMTI NK STIM
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday's morning session, 342 companies made new 52-week highs. Intriguing Points: The largest company by ... 
Tags BSET OXFD PCTY
From Benzinga
First Week of ACRS August 2021 Options Trading
Investors in Aclaris Therapeutics Inc (ACRS) saw new options begin trading this week, for the August 2021 expiration. One of the key data points that goes into the price an option buyer is willing to... 
Tags Stocks
From Market News Video
Thinking about buying stock in MacroGenics, Arbutus Biopharma, Riot Blockchain, Aclaris Therapeutics, or Myovant Sciences?
InvestorsObserver issues critical PriceWatch Alerts for MGNX, ABUS, RIOT, ACRS, and MYOV. 
From PR Newswire
Aclaris Therapeutics Reaches Analyst Target Price
In recent trading, shares of Aclaris Therapeutics Inc (ACRS) have crossed above the average analyst 12-month target price of $4.83, changing hands for $5.01/share. When a stock reaches the target an... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.